ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

How Do Anhepatic Patients Fair? A Single-Center Experience of Thirteen Patients Requiring Total Hepatectomy and Portocaval Shunting for Severe Hepatic Dysfunction

K. Lau, A. Zarrinpar, V. Agopian, F. Kaldas, D. Farmer, R. Busuttil

Department of Surgery, The Dumont-UCLA Liver Transplant Center, Los Angeles, CA

Meeting: 2013 American Transplant Congress

Abstract number: A605

BACKGROUND/AIMS:

Total hepatectomy with portocaval shunting (TH-PS) is a last-resort in patients with severe acute liver dysfunction awaiting liver transplantation (LT). The anhepatic state portends dismal outcomes. We describe characteristics and survival rates of patients who underwent TH-PS.

METHOD:

Retrospective analysis of LT recipients from a single academic institution from 1999-2012. Measures included demographics, indication for TH-PS, ABO compatibility, and anhepatic time (AT). The primary outcome was 30 day mortality. AT was dichotomized by times less than or greater than 24 hours. Fisher’s exact test was used to compare mortality between groups.

RESULTS:

Thirteen anhepatic patients were identified, ages 7 months to 61 years. Six (46.1%) were female. 12 underwent salvage LT and 1 died awaiting transplantation. The indications for TH-PS were acute liver failure (n=3, 23.1%), allograft dysfunction after LT due to primary nonfunction (n=7, 53.8%), vascular thrombosis (n=2, 15.4%), and hemorrhage (n=1, 7.7%). ABO incompatible grafts were used in 4 (33.3%). The overall 1, 3 and 5 years survival rates were 54 % (n=7), 46 %( n=6) and 46% (n=6). Patients who underwent LT with AT < 24 hours (n=9, 75.0%) had 100% 30-day and 78% 1-year survival, while patients underwent LT with AT >24 hours (n=3, 25.0%) had no survival at 30 days. 30 day mortality was significantly higher in those with AT>24 hrs, p=0.004.

CONCLUSIONS:

TH-PS can be life-saving in patients with severe hepatic dysfunction awaiting LT. AT>24 hours is associated with higher mortality. Efforts to minimize AT may require delaying TH-PS until confirmation that a donor is available.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lau K, Zarrinpar A, Agopian V, Kaldas F, Farmer D, Busuttil R. How Do Anhepatic Patients Fair? A Single-Center Experience of Thirteen Patients Requiring Total Hepatectomy and Portocaval Shunting for Severe Hepatic Dysfunction [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/how-do-anhepatic-patients-fair-a-single-center-experience-of-thirteen-patients-requiring-total-hepatectomy-and-portocaval-shunting-for-severe-hepatic-dysfunction/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences